Back to Search
ROBERT PEDERSON, MD
MD
Interventional Cardiology Physician
NPI: 1710987813Individual
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
E1920(TX)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
E1920(TX)
Research & Publications (20)
Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.
PMID 19602585·Am J Physiol Endocrinol Metab·2009
7-preclinical
Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat.
PMID 17803965·Biochem Biophys Res Commun·2007
7-preclinical
Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM).
PMID 16700515·Adv Exp Med Biol·2006
6-review
Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus.
PMID 16442340·Int J Biochem Cell Biol·2006
6-review
Type 2 diabetes--therapy with dipeptidyl peptidase IV inhibitors.
PMID 15978877·Biochim Biophys Acta·2005
6-review
Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?
PMID 15780435·Regul Pept·2005
6-review
Effects of cooperative learning strategy on undergraduate kinesiology students' learning styles.
PMID 16383090·Percept Mot Skills·2005
8-other
[Ser2]- and [SerP2] incretin analogs: comparison of dipeptidyl peptidase IV resistance and biological activities in vitro and in vivo.
PMID 14610075·J Biol Chem·2004
4-observational
In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide.
PMID 15302229·Life Sci·2004
7-preclinical
Structure-function analysis of a series of novel GIP analogues containing different helical length linkers.
PMID 12627975·Biochemistry·2003
4-observational
Dipeptidyl peptidase IV inhibition in animal models of diabetes.
PMID 12675250·Adv Exp Med Biol·2003
7-preclinical
Glucose-dependent insulinotropic polypeptide (GIP): development of DP IV-resistant analogues with therapeutic potential.
PMID 12675251·Adv Exp Med Biol·2003
7-preclinical
A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells.
PMID 12475913·FASEB J·2003
7-preclinical
Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.
PMID 12610046·Diabetes Care·2003
3-trial
Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
PMID 12540373·Am J Physiol Endocrinol Metab·2003
7-preclinical
Effect of a fruit and vegetable subscription in Danish schools.
PMID 12581466·Public Health Nutr·2003
3-trial
Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
PMID 12606516·Diabetes·2003
7-preclinical
Influence of phytostanol phosphoryl ascorbate (FM-VP4) on insulin resistance, hyperglycemia, plasma lipid levels, and gastrointestinal absorption of exogenous cholesterol in Zucker (fa/fa) fatty and lean rats.
PMID 12532378·J Pharm Sci·2003
7-preclinical
Structure-activity relationships of glucose-dependent insulinotropic polypeptide (GIP).
PMID 12715891·Biol Chem·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 207 E BUENA VISTA ST
SANTA FE, NM 87505 - Phone
- (512) 970-3666
Quick Facts
- NPI
- 1710987813
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile